LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 314 of 535
Next
>>
>
7826 to 7850 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	JNK-9L	3.33	uM	LJP6	2	K20	72	hr	1097	980	3713	0.2639	-0.0622
BT-20	JNK-9L	3.33	uM	LJP6	3	K20	72	hr	1097	865	3696	0.2340	-0.1269
BT-20	JNK-9L	10	uM	LJP6	1	K19	72	hr	1097	781	3610	0.2163	-0.1795
BT-20	JNK-9L	10	uM	LJP6	2	K19	72	hr	1097	808	3713	0.2176	-0.1597
BT-20	JNK-9L	10	uM	LJP6	3	K19	72	hr	1097	787	3696	0.2129	-0.1728
BT-20	PD0325901	0.04	uM	LJP6	1	E06	72	hr	1097	3509	3610	0.9719	0.9671
BT-20	PD0325901	0.04	uM	LJP6	2	E06	72	hr	1097	3058	3713	0.8234	0.7909
BT-20	PD0325901	0.04	uM	LJP6	3	E06	72	hr	1097	3413	3696	0.9233	0.9110
BT-20	PD0325901	0.04	uM	LJP5	1	C06	72	hr	1097	2749	3735	0.7360	0.6815
BT-20	PD0325901	0.04	uM	LJP5	2	C06	72	hr	1097	2862	3877	0.7381	0.6928
BT-20	PD0325901	0.04	uM	LJP5	3	C06	72	hr	1097	3301	3925	0.8409	0.8202
BT-20	PD0325901	0.12	uM	LJP6	1	E05	72	hr	1097	3062	3610	0.8481	0.8171
BT-20	PD0325901	0.12	uM	LJP6	2	E05	72	hr	1097	3193	3713	0.8598	0.8354
BT-20	PD0325901	0.12	uM	LJP6	3	E05	72	hr	1097	3202	3696	0.8662	0.8426
BT-20	PD0325901	0.12	uM	LJP5	1	C05	72	hr	1097	3049	3735	0.8163	0.7830
BT-20	PD0325901	0.12	uM	LJP5	2	C05	72	hr	1097	2794	3877	0.7205	0.6706
BT-20	PD0325901	0.12	uM	LJP5	3	C05	72	hr	1097	3440	3925	0.8763	0.8615
BT-20	PD0325901	0.37	uM	LJP6	1	E04	72	hr	1097	2860	3610	0.7921	0.7463
BT-20	PD0325901	0.37	uM	LJP6	2	E04	72	hr	1097	2774	3713	0.7470	0.6943
BT-20	PD0325901	0.37	uM	LJP6	3	E04	72	hr	1097	2752	3696	0.7445	0.6901
BT-20	PD0325901	0.37	uM	LJP5	1	C04	72	hr	1097	2875	3735	0.7697	0.7247
BT-20	PD0325901	0.37	uM	LJP5	2	C04	72	hr	1097	2990	3877	0.7711	0.7340
BT-20	PD0325901	0.37	uM	LJP5	3	C04	72	hr	1097	2862	3925	0.7291	0.6843
BT-20	PD0325901	1.11	uM	LJP6	1	E03	72	hr	1097	2303	3610	0.6379	0.5395
BT-20	PD0325901	1.11	uM	LJP6	2	E03	72	hr	1097	2443	3713	0.6578	0.5763

|<
<<
Previous
Page 314 of 535
Next
>>
>
7826 to 7850 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)